[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578415":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":25,"responsibleParty":36,"collaborators":25,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":25,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":25,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":61,"overallStatus":68,"whyStopped":25,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":25},{"fullName":5,"class":6},"Babes-Bolyai University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental Group","EXPERIMENTAL","This arm is the experimental group which will receive the intervention. The intervention is a one session From Fear to Purpose ACT Protocol, which is built on Acceptance and Commitment Therapy (ACT) strategies, focused on identifying and committing to personal values.",[13],"Other: From Fear to Purpose (Acceptance and Commitment Therapy)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo Group","PLACEBO_COMPARATOR","This arm is the placebo group, which will be undergoing a group-based attentional control intervention.",[19],"Other: Placebo",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"From Fear to Purpose (Acceptance and Commitment Therapy)","The From Fear to Purpose ACT Protocol is based on Acceptance and Commitment Therapy (ACT) strategies, build around identifying and committing to personal values. The intervention will be group-based (90 minutes session).",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","The placebo condition consists of a group-based attentional control intervention.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Roxana Cardoș, PhD","CONTACT","0040751477323","roxanaoltean@psychology.ro",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Roxana Cardos","PhD","100578415","from-fear-to-purpose-act-protocol-implications-of-death-anxiety-in-depression-and-anxiety-symptoms-100578415",false,"NCT06810999","From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.","From Fear to Purpose ACT Protocol: Testing Indirect, Transdiagnostic Implications of Death Anxiety Over Depression and Anxiety. A Randomized Placebo Controlled Trial.","Inclusion Criteria:\n\n* Moderate-high levels of death anxiety (score \\> or = 55) AND\n* Subclinical levels of depression (score \\> or = 9) AND\u002FOR\n* Subclinical levels of anxiety (score \\> or = 9)\n\nExclusion Criteria:\n\n* Minors\n* Suicidal ideation\n* Current psychological\u002Fpsychiatric diagnosis (except depression or anxiety diagnosis)\n* Active psychological\u002Fpsychiatric treatment","ALL","18 Years","65 Years",{"count":51,"type":52},175,"ESTIMATED","INTERVENTIONAL",[55],"NA","The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.",[58,59,60],"Death Anxiety","Depression","Anxiety",[62,63,64,65,66,67],"death anxiety","depression","anxiety","transdiagnostic","indirect intervention","rct","NOT_YET_RECRUITING","2025-04-16",{"date":71,"type":72},"2025-04-18","ACTUAL",{"date":74,"type":52},"2025-06-01",{"date":76,"type":52},"2025-12-30",{"name":5,"class":6}]